Status | Study |
Completed |
Study Name: Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis Condition: Ulcerative Colitis Date: 2012-06-01 Interventions: Drug: ASP3291 Tablet, 1,000 mg |
Terminated |
Study Name: Intracolonic Vancomycin Therapy in Severe C. Diff Colitis Condition: Colitis Date: 2011-03-03 Interventions: Drug: Vancomycin Vancomycin so |
Terminated |
Study Name: Basiliximab Maintenance in Ulcerative Colitis Condition: Ulcerative Colitis Date: 2010-02-02 Interventions: Drug: Basiliximab Study Drug: basiliximab 40 mg, given as a short intravenous infusion Dosing Schedule: |
Withdrawn |
Study Name: Lactobacillus GG in Pediatric Ulcerative Colitis (UC) Condition: Ulcerative Colitis Date: 2009-04-27 Interventions: Biological: Lactobacillus GG 1 capsule taken twice daily for a minimum of 28 days to a maximum of 35 day |
Completed |
Study Name: A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis Condition: Ulcerative Colitis Date: 2009-02-27 Interventions: Biological: adalimumab Other N |
Terminated |
Study Name: Effects of Probiotics in Patients With Ulcerative Colitis Condition: Ulcerative Colitis Date: 2007-12-18 Interventions: Dietary Supplement: Kyo-Dophilus |
Completed |
Study Name: Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis Condition: Ulcerative Colitis Date: 2007-12-12 Interventions: Biological: adalimumab Prefilled syringes 40 mg EOW subcutaneous and prefilled syringes 40 mg weekly sub |
Completed |
Study Name: Basiliximab in Moderate to Severe Ulcerative Colitis Condition: Ulcerative Colitis Date: 2007-01-31 Interventions: Drug: Basiliximab 3 doses of 40mg, IV at baseline, week 2, and week 4 |
Completed |
Study Name: Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis Condition: Ulcerative Colitis Date: 2006-03-02 Interventions: Drug: COLAL-PRED® COLAL-P |
Completed |
Study Name: Rituximab in Active Ulcerative Colitis Condition: Ulcerative Colitis Date: 2005-11-29 Interventions: Drug: Rituximab Rituximab 1g in 500 mls Normal Saline Placebo 500 mls Normal Saline |